Equity Leaders Weekly

 iShares US Telecommunications ETF (IYZ) & iShares NASDAQ Biotechnology ETF (IBB)

What a week for US markets! In the last few days, the Dow Jones Industrial Average, Dow Jones Transportation Average, S&P 100, S&P 500, Russell 2000, NASDAQ Composite and the NYSE Composite Indexes have all achieved new all-time highs. With index moves showing gains in large-cap, small-cap, concentrated and broad indices, investor confidence and interest in stocks remains high. What is most amazing about the current advance is that it arrives in the face of a lot of current uncertainty confirming the old saying “bull markets climb a wall of worry”. The first approved COVID vaccine rollout has encouraged investors to look past the current wave of lockdowns toward an eventual potential recovery. Meanwhile, there are still a number of issues to be dealt with in the near term including US stimulus/budget negotiations looking to head off a government shutdown and extend support programs, UK-EU trade negotiations with a deadline apparently set for Monday December 14th, and another court challenge to the US election, this time from several states, ahead of next week’s Electoral College vote. The coming week is the last regular business week before the two-week holiday slowdown begins. Several central banks are holding their last meetings of the year including the US Fed, Bank of England, Bank of Japan and others. Economic news is headlined by flash PMI, retail sales and industrial production reports. There are also a few scattered earnings reports, headlined by FedEx, Nike and Blackberry.  In this week’s issue of Equity Leaders Weekly, we look at what recent breakouts in the telecom and biotech sectors are telling us about market breadth and investor confidence. 

iShares US Telecommunications ETF (IYZ) 

While many communications companies, particularly in the internet content, streaming, and social media areas have exhibited strong growth in the last decade, the carriers which comprise the telecommunications part of the sector have been generally viewed by investors as a stable, lower growth, defensive, interest sensitive area, more similar with utilities.Action in the iShares US Telecommunications ETF (IYZ) since the March market bottom showed a moderate spring recovery which fell short of its previous peak, then sideways consolidation resumed between June and November. In the last month, the sector has started to attract increased attention, completing a bullish Spread Triple Top pattern and IYZ broke through $30.65 to trade at its highest level since the summer of 2017. This breakout occurring in concert with new highs for broad-based US indices can be seen as a sign of strong breath, and a healthy bull market with participation from a broad variety of sectors. Next potential upside resistance for IYZ appears near $34.55 and then $37.05, which are based on vertical and horizontal counts. Initial support appears near $29.45 based on a 3-box reversal.

iShares NASDAQ Biotechnology ETF (IBB)

Biotechnology has historically been seen by investors as the development side of health care, carrying the potential for higher returns, but also higher risks relative to Big Pharma and some of the other, more defensive parts of the health care sector. Because of this, action in biotech can be seen as a sign of investor appetite at a point in time. Back in the spring the iShares NASDAQ Biotechnology ETF (IBB) was one of the first sectors to fully recover the ground lost in the February-March market crash. IBB broke out to a new 52-week high in April, and continued to charge forward until July, then spent the ensuing months through November digesting its gains in a higher range. In the last month, IBB has come under renewed accumulation, completing bullish Triple Top, Double Top and Spread Double Top patterns, the last of which signaled that the consolidation phase is over, a new upleg is underway, and that investors remain enthusiastic as broader indices achieve new all-time highs. Next potential upside resistance for IBB appears near $157.00 and $166.70 based on vertical and horizontal counts. Initial support appears near $143.55 based on a 3-box reversal.  

Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.